Literature DB >> 2045101

The human chromosome content in human x rodent somatic cell hybrids analyzed by a screening technique using Alu PCR.

D C Bicknell1, D Markie, N K Spurr, W F Bodmer.   

Abstract

The ubiquitous nature of the Alu sequence throughout the human genome forms the basis of an assay we present here for analyzing the human chromosome content of human x rodent somatic cell hybrids. A human-specific Alu primer was used both to amplify sequences and to 32P label the products in a polymerase chain reaction (PCR) technique. Unlabeled inter-Alu PCR products from two series of human x rodent hybrids were used to prepare dot blots which were probed with labeled inter-Alu products prepared from between 10(3) and 10(4) hybrid cells. In the first series we demonstrate that a labeled inter-Alu probe from the hybrid DL18ts, containing a single chromosome 18, on a dot blot hybridized only with those inter-Alu products containing chromosome 18. Similar specificity for human chromosome 5 was shown when a Southern blot of the PCR products was hybridized with a probe made from the hybrid HHW 213, which contains only chromosome 5p. Using a dot blot from a second series of control hybrids, 15 of which contained single human chromosomes, hybridization of a labeled probe from the hybrid 18X4-1 was shown to react specifically with the controls that expressed chromosome 18. Application of the technique reported here allows simple and rapid characterization of the human chromosome content in human x rodent hybrids.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2045101     DOI: 10.1016/0888-7543(91)90499-5

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  2 in total

1.  Beta 2-microglobulin gene mutations: a study of established colorectal cell lines and fresh tumors.

Authors:  D C Bicknell; A Rowan; W F Bodmer
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

2.  An epitope on carcinoembryonic antigen defined by the clinically relevant antibody PR1A3.

Authors:  H Durbin; S Young; L M Stewart; F Wrba; A J Rowan; D Snary; W F Bodmer
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-10       Impact factor: 11.205

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.